John Vos MD, PhD

In 1998 John DeVos obtained his diploma as a Doctor (Clinical Hematology) at the Faculty of Medicine Saint-Antoine, Paris VI. In 2001 he completed a Doctorate in “Chemical and Biological Sciences for Health” at Montpellier I University.

In university and hospital activities, he has focused on developing cell therapy and knowledge around stem cells at the national and international levels. Cell therapy makes it possible to treat pathologies that are beyond the use of drugs and surgery by injecting “drug” cells. It is at the heart of a young branch of medicine, regenerative medicine. Associated with gene therapy, it makes it possible to consider the correction of a certain number of genetic pathologies. His teaching is aimed at students from the first year of medicine (PACES) to doctors in the context of post-graduate education, including numerous master's degrees. He is responsible for the University Diploma in Regenerative Medicine (UM), and several teaching units. In addition, he has a strong supervisory activity: UTC interns and students from the research team.

Since 2009, he has been responsible for the Cellular Therapy Unit (UTC) at Montpellier University Hospital. Since 2014 he has also been coordinator of the Cellular and Tissue Engineering Department of the University Hospital and Director of the Placental Blood Bank. He created the “pluripotent stem cells” theme within the IRMB and published the first work of a French team on human embryonic stem cells in 2007 (Stem Cells, Assou, et al.).

His research work has resulted in a total of 103 publications in international peer-reviewed journals, totaling a Hirsh Factor of 48. Jhon De Vos is co-founder of the start-ups Stemgenomics (iLab Prize 2018, iNov Prize 2019) and MedXCell Science, founder and vice-president of the French Society for Stem Cell Research (FSSCR) since 2017.